These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2113526)

  • 1. Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms.
    Vander Jagt DL; Hunsaker LA; Robinson B; Stangebye LA; Deck LM
    J Biol Chem; 1990 Jul; 265(19):10912-8. PubMed ID: 2113526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose and aldehyde reductase in animal tissues.
    Flynn TG
    Metabolism; 1986 Apr; 35(4 Suppl 1):105-8. PubMed ID: 3083200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of aldose reductase from human placenta and stabilization of the inhibitor binding site.
    Vander Jagt DL; Stangebye LA; Hunsaker LA; Eaton RP; Sibbitt WL
    Biochem Pharmacol; 1988 Mar; 37(6):1051-6. PubMed ID: 3128293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase from human psoas muscle. Purification, substrate specificity, immunological characterization, and effect of drugs and inhibitors.
    Morjana NA; Flynn TG
    J Biol Chem; 1989 Feb; 264(5):2906-11. PubMed ID: 2492526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase from human skeletal and heart muscle. Interconvertible forms related by thiol-disulfide exchange.
    Vander Jagt DL; Robinson B; Taylor KK; Hunsaker LA
    J Biol Chem; 1990 Dec; 265(34):20982-7. PubMed ID: 2174432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hexonate dehydrogenase and aldose reductase from bovine retina by sorbinil, statil, M79175 and valproate.
    Poulsom R
    Biochem Pharmacol; 1986 Sep; 35(17):2955-9. PubMed ID: 3091036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ponalrestat: a potent and specific inhibitor of aldose reductase.
    Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
    Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human kidney aldose and aldehyde reductases.
    Sato S; Kador PF
    J Diabetes Complications; 1993; 7(3):179-87. PubMed ID: 8343612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of aldose reductase and aldehyde reductase from EHS tumor cells.
    Tanimoto T; Sato S; Kador PF
    Biochem Pharmacol; 1990 Feb; 39(3):445-53. PubMed ID: 2106320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human placental aldose reductase: role of Cys-298 in substrate and inhibitor binding.
    Bhatnagar A; Liu SQ; Ueno N; Chakrabarti B; Srivastava SK
    Biochim Biophys Acta; 1994 Apr; 1205(2):207-14. PubMed ID: 8155699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of aldose reductase from human tissues.
    Das B; Srivastava SK
    Diabetes; 1985 Nov; 34(11):1145-51. PubMed ID: 3930326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type.
    Poulsom R
    Biochem Pharmacol; 1987 May; 36(10):1577-81. PubMed ID: 3109423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
    Carbone V; Zhao HT; Chung R; Endo S; Hara A; El-Kabbani O
    Bioorg Med Chem; 2009 Feb; 17(3):1244-50. PubMed ID: 19121944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of sulfhydryl residues in aldose reductase-inhibitor interaction.
    Bhatnagar A; Liu S; Das B; Srivastava SK
    Mol Pharmacol; 1989 Dec; 36(6):825-30. PubMed ID: 2513474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE; Lai CJ
    Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH-dependent reductases in dog thyroid: comparison of a third enzyme "glyceraldehyde reductase" to dog thyroid aldehyde reductase.
    Schaffhauser MA; Sato S; Kador PF
    Int J Biochem Cell Biol; 1996 Mar; 28(3):275-84. PubMed ID: 8920636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.